Hormone Replacement Trial Against ALzheimers' Disease

NARecruitingINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

April 17, 2018

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions

Postmenopausal SymptomsAlzheimer Disease

Interventions

PROCEDURE

blood take

Blood is taken to analyse degradation products of the metabolism of amyloid

Trial Locations (1)

RECRUITING

Ghent university hospital, Ghent

All Listed Sponsors

lead

University Hospital, Ghent

OTHER